Search - tctmd.com

Displaying 141 - 160 of 224

Sort: Relevancy | Date

News Conference News ACC 2017

ABSORB III: Two-Year Results Show a Higher MACE Rate Compared With Xience

Michael O'Riordan

March 18, 2017

News Conference News ACC 2017

FDA Warns of Risk of Major Adverse Cardiac Events With Absorb BVS

Michael O'Riordan

March 18, 2017

News Daily News

‘Hub and Spoke’ Model Promises to Improve Access to PCI for STEMI in Low- and Middle-Income Countries

L.A. McKeown

March 14, 2017

News Conference News ACC 2017

ACC 2017: CVD Outcomes for Evolocumab, Intermediate-Risk TAVR, Coronary Physiology Tests, and More

Shelley Wood

March 10, 2017

News Daily News

Less Acute MI, More HF: European Task Force Shifts Support for ‘Overhyped’ Cell Therapy Research

Yael L. Maxwell

February 22, 2017

News Conference News CRT 2017

Absorb BVS: Better Technique, Better Outcomes? More Data—and More Debate

Michael O'Riordan

February 21, 2017

$The Coronary Sinus Reducer: A Device Based Therapy for Refractory Angina$

Presentation JIM 2017

The Coronary Sinus Reducer: A Device Based Therapy for Refractory Angina

Presenter: Francesco Giannini

February 10, 2017

News Daily News

10-Year Follow-up of Early DES Shows Steady Risk of Late Events

L.A. McKeown

February 08, 2017

News Daily News

Device, Operator, or Lesion: What Affects Long-term Outcomes With Bioresorbable Scaffolds?

Michael O'Riordan

February 02, 2017

News Features

Be It Resolved: Lifestyle Changes for Patients Needing Cardiac Rehab May Be a Life or Death Matter

Michael O'Riordan

January 10, 2017

News Features

Year in Review: Physicians Pick the Biggest News of 2016, in Interventional Cardiology and Beyond

Shelley Wood

December 30, 2016

News Daily News

Anemia Common in ACS Patients, Linked with Higher Mortality

Michael O'Riordan

November 23, 2016

News Conference News TCT 2016

No Scares From SCAAR: Stent Thrombosis Rates in Newest DES Are Similar—and Low

Shelley Wood

November 07, 2016

News Conference News TCT 2016

‘Worrisome’ 3-Year Data From ABSORB II Raise Concerns About First-Generation Bioresorbable Stent

Michael O'Riordan

October 30, 2016

News Conference News TCT 2016

DES With Biodegradable Polymers Stand Up Well Against Durable-Polymer Stents in the Short Term

Todd Neale

October 30, 2016

News Conference News TCT 2016

Impella CP Fails to Show Benefit in Exploratory Study of Patients With Severe Cardiogenic Shock

Todd Neale

October 29, 2016

News Daily News

Heavy Burden of Residual Thrombus After Thrombectomy Signals Worse Primary PCI Results

Todd Neale

October 03, 2016

News Features

The Bioresorbable Stent Story So Far: What Promise? What Price?

Michael O'Riordan

August 17, 2016

News Daily News

Bad Breaths: Atherosclerosis, Adverse Cardiac Outcomes Linked to Air Pollution

Yael L. Maxwell

August 03, 2016

News Daily News

Survey of Interventional Cardiologists With Absorb BVS Expertise Gives Snapshot of Attitudes, Usage

Michael O'Riordan

June 14, 2016

Advertisement

ABSORB III: Two-Year Results Show a Higher MACE Rate Compared With Xience

FDA Warns of Risk of Major Adverse Cardiac Events With Absorb BVS

‘Hub and Spoke’ Model Promises to Improve Access to PCI for STEMI in Low- and Middle-Income Countries

ACC 2017: CVD Outcomes for Evolocumab, Intermediate-Risk TAVR, Coronary Physiology Tests, and More

Less Acute MI, More HF: European Task Force Shifts Support for ‘Overhyped’ Cell Therapy Research

Absorb BVS: Better Technique, Better Outcomes? More Data—and More Debate

The Coronary Sinus Reducer: A Device Based Therapy for Refractory Angina

10-Year Follow-up of Early DES Shows Steady Risk of Late Events

Device, Operator, or Lesion: What Affects Long-term Outcomes With Bioresorbable Scaffolds?

Be It Resolved: Lifestyle Changes for Patients Needing Cardiac Rehab May Be a Life or Death Matter

Year in Review: Physicians Pick the Biggest News of 2016, in Interventional Cardiology and Beyond

Anemia Common in ACS Patients, Linked with Higher Mortality

No Scares From SCAAR: Stent Thrombosis Rates in Newest DES Are Similar—and Low

‘Worrisome’ 3-Year Data From ABSORB II Raise Concerns About First-Generation Bioresorbable Stent

DES With Biodegradable Polymers Stand Up Well Against Durable-Polymer Stents in the Short Term

Impella CP Fails to Show Benefit in Exploratory Study of Patients With Severe Cardiogenic Shock

Heavy Burden of Residual Thrombus After Thrombectomy Signals Worse Primary PCI Results

The Bioresorbable Stent Story So Far: What Promise? What Price?

Bad Breaths: Atherosclerosis, Adverse Cardiac Outcomes Linked to Air Pollution

Survey of Interventional Cardiologists With Absorb BVS Expertise Gives Snapshot of Attitudes, Usage

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content